主要剂量限制性毒性为骨髓抑制。
在研究过程中未发现剂量限制性毒性。
我们在慢速输液(没有前驱给药)的情况下还没有看到剂量限制性毒性,只看到两例患者出现头痛,是中等不良反应。
While we have not seen dose-limiting toxicity at this level with the slower infusion (without pre-medication), we have seen headache in two patients, which is a moderate adverse effect.
我们在慢速输液(没有前驱给药)的情况下还没有看到剂量限制性毒性,只看到两例患者出现头痛,是中等不良反应。
While we have not seen dose-limiting toxicity at this level with the slower infusion (without pre-medication), we have seen headache in two patients, which is a moderate adverse effect.
应用推荐